The Influence of Melanoma Extracellular Vesicles on Benign Melanocytes: A Role for PRAME in Modulation of the Tumor

Xiaochen Liu1, Ralf Janknecht2, Sepideh Nikki Asadbeigi1

  • 1Department of Pathology, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA; Department of Dermatology, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.

Insights

Preferentially expressed antigen in melanoma (PRAME) in extracellular vesicles promotes melanoma progression by altering benign melanocyte behavior. Targeting PRAME-loaded EVs may inhibit melanoma metastasis and improve therapy response.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Biology

Background:

  • Melanoma is an aggressive skin cancer known for metastasis and therapy resistance.
  • Preferentially expressed antigen in melanoma (PRAME), a cancer-testis antigen, is implicated in tumor progression.
  • Extracellular vesicles (EVs) mediate intercellular communication and play roles in cancer.

Purpose of the Study:

  • To investigate the role of PRAME in melanoma progression.
  • To determine PRAME's function within melanoma-derived EVs.
  • To assess the impact of PRAME-carrying EVs on benign melanocytes.

Main Methods:

  • Analysis of PRAME expression in melanoma cell lines, tissues, and patient plasma.
  • Isolation and characterization of PRAME from melanoma EVs.
  • Co-culture experiments with melanoma EVs and benign melanocytes.
  • PRAME gene knockout in melanoma cells.

Main Results:

  • PRAME is highly expressed in melanoma and detected in EVs.
  • Melanoma EVs transfer PRAME (protein and mRNA) to benign melanocytes.
  • PRAME transfer induces gene expression changes, increased proliferation, and malignant phenotype in melanocytes.
  • PRAME knockout diminishes EV-mediated protumorigenic effects on melanocytes.

Conclusions:

  • PRAME is actively secreted via EVs and drives melanoma progression.
  • PRAME in EVs facilitates intercellular communication, promoting a malignant phenotype.
  • Plasma EV-associated PRAME shows potential as a biomarker for melanoma monitoring.
  • Targeting PRAME-containing EVs presents a novel therapeutic strategy against melanoma metastasis.

Related Concept Videos

The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.5K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K